CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06147414
Title field or adapter rule: {'original_value': 'Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:22.799983+00:00
Published At: 2026-10-21T00:00:00+00:00
Record Updated At: 2026-10-21
Source Retrieved At: 2026-10-31T22:17:25.750886+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

protocolSection.conditionsModule.conditions: ["Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including", "Sickle Cell Disease", "Cystic Fibrosis", "Fragile X Syndrome", "Proximal Spinal Muscular Atrophy", "Myotonic Dystrophy", "Muscular Dystrophy, Duchenne", "Muscular Dystrophy, Becker", "Neurofibromatosis-Noonan Syndrome", "Huntington Disease", "Hemophilia A", "Hemophilia B", "MODY2 Diabetes", "X-Linked Hydrocephalus", "Autosomal Recessive Polycystic Kidney Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-21", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT06147414"
protocolSection.identificationModule.officialTitle: "Evaluation of the Diagnostic Performance of Non-Invasive Prenatal Diagnosis for Single Gene Disorders"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: null
protocolSection.statusModule.resultsFirstPostDateStruct: null

{'armGroupLabels': ['pregnant women undergoing invasive PND in a context of family history of SGD', 'pregnant women undergoing prenatal counselling in a context of maternal history of diabetes MODY-GCK'], 'description': 'A blood sample (50 ml) will be taken in care of prenatal diagnosis and 40 ml will be used for study.\n\nThe 40 mL of blood needed for the research will be collected on BCT tubes (4 tubes).\n\nDuring the study, in centers, the plasma samples will be stored at room temperature and will be sent to the laboratory within 24 hours (no centrifugation in centers).\n\nThe plasma samples will be then temporarily stored at -80°C in each co-investigating laboratory under the supervision of lab supervisor until the analysis. cfDNA will be extracted from the whole plasma sample before each sequencing run and stored à +4°C until the cfDNA sequencing.', 'name': 'Blood sample', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.